Month: February 2018

Johnson & Johnson ’s JNJ subsidiary, Janssen, announced that the FDA has granted approval to its prostate cancer drug, Zytiga, (abiraterone acetate) in combination with prednisone to treat an early stage of prostate cancer. Notably, Zytiga, was earlier approved in both the United States and the EU to treat metastatic castration-resistant prostate cancer (mCRPC) in treatment-experienced patients, whose chemotherapy contained docetaxel. With this latest nod from the regulatory body, the drug’s label has been expanded to treat newly-diagnosed patients with metastatic high-risk castration-sensitive prostate cancer (CSPC) […]

Mettler-Toledo International Inc. MTD reported impressive fourth-quarter 2017 results. […]

Watsco, Inc. WSO posted adjusted earnings per share of 90 cents in fourth-quarter 2017, up 11% year over year. […]

Franklin Resources Inc. BEN has announced preliminary assets under management (AUM) by its subsidiaries of $770.8 billion for January 2018. Results display 2.3% rise from $753.8 billion recorded as of Dec 31, 2017 […]

As we are about to enter another eventful week of the current reporting cycle, real estate investment trust (REIT) will be seeing a really busy Monday. Admittedly, the December rate hike and possibilities of further increases in rates this year have kept investors in the REIT space worried to some extent. However, underlying asset categories and location of properties play a crucial role in determining the performance of REITs. […]

Patterson-UTI Energy Inc. PTEN shares plunged 14.3% Thursday after the onshore contract driller reported adjusted net loss per share of 10 cents, 2 cents wider than the Zacks Consensus Estimate on soaring expenses. The company is already grappling with the aftermath of the recent explosion in a well in Quinton, OK, owned by Red Mountain Energy […]

On Feb 8, we issued an updated research report on AmerisourceBergen Corporation ABC . The company continues to gain form solid organic growth, World Courier Business, H.D. Smith Acquisition and deal with Walgreens. […]

Leading Canadian telecom operator, BCE Inc . BCE reported mixed financial results in the fourth quarter of 2017. The top line failed to meet the Zacks Consensus while the bottom line surpassed the same. […]

Beacon Roofing Supply, Inc. BECN reported adjusted earnings of 68 cents per share in the first-quarter fiscal 2018. […]

Moody's Corporation MCO reported fourth-quarter 2017 adjusted earnings of $1.51 per share, which handily surpassed the Zacks Consensus Estimate of $1.45. Also, the bottom line improved 20% from the year-ago quarter. Results were attributable to impressive revenue growth, reflecting strong issuance in the quarter. […]

Melco Resorts & Entertainment Limited MLCO posted mixed fourth-quarter 2017 results, with the top line surpassing the Zacks Consensus Estimate and the bottom line missing the same. Adjusted earnings of 20 cents per share missed the consensus mark of 23 cents by 13% but grew 58.9% year over year. The upside was driven by higher casino revenues from Studio City and Altira Macau, partially offset by lower revenues from City of Dreams in Macau. […]

Italian oil giant Eni S.p.A. E recently reported the discovery of a potential natural gas field at the Calypso prospect, located in Block 6 offshore Cyprus. The company has partnered with France's Total S.A […]

ViaSat Inc. VSAT reported third-quarter fiscal 2018 adjusted loss of 4 cents per share, down drastically from earnings of 29 cents recorded in the year-ago quarter. […]

Potbelly Corporation PBPB is expected to release fourth-quarter 2017 results on Feb 13. While we expect the company to record an increase in revenues driven by unit growth and sales initiatives, comps are likely to decline, given weak consumer demand coupled with food inflation. We observe that shares of Potbelly have depreciated 8.5% over the last year against the industry ’s gain of 8.5%. […]

The fourth-quarter 2017 earnings season is in full swing with 322 members of the elite S&P 500 index having reported financial numbers already. Per the latest Earnings Outlook , performances indicate a 15% increase in total earnings on 9.2% higher revenues. The beat ratio is impressive with 79.8% companies surpassing bottom-line expectations and 77%, outperforming on the top line. […]

With externalities impacting stock markets every second day, investors with varied risk appetite prefer to go for value investing. In the event of a market crash, investors often end up to selling their holdings in a panic. […]